Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis

BACKGROUND: Although chemotherapeutic regimens containing a taxane or platinum agent have been widely recommended for unfavourable carcinoma of unknown primary (CUP), no evidence exists for the superiority of any administered regimens. To date, the efficacy has been mostly assessed in the limited se...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, J, Hahn, S, Kim, D-W, Kim, J, Kang, S N, Rha, S Y, Lee, K B, Kang, J-H, Park, B-J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553519/
https://www.ncbi.nlm.nih.gov/pubmed/23175147
http://dx.doi.org/10.1038/bjc.2012.516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553519/
https://www.ncbi.nlm.nih.gov/pubmed/23175147
http://dx.doi.org/10.1038/bjc.2012.516

Ejemplares similares